Agentic Framework for Epidemiological Modeling
Rituparna Datta, Zihan Guan, Baltazar Espinoza, Yiqi Su, Priya Pitre, Srini Venkatramanan, Naren Ramakrishnan, Anil Vullikanti

TL;DR
EPIAGENT is an agentic framework that automates the synthesis, calibration, and verification of epidemiological models, enabling adaptable and consistent epidemic simulations that incorporate complex dynamics and counterfactual scenarios.
Contribution
It introduces an explicit flow graph intermediate representation and an agentic feedback loop to automate and improve epidemiological modeling processes.
Findings
Captures complex epidemic growth dynamics.
Produces consistent counterfactual projections.
Accelerates convergence to valid models.
Abstract
Epidemic modeling is essential for public health planning, yet traditional approaches rely on fixed model classes that require manual redesign as pathogens, policies, and scenario assumptions evolve. We introduce EPIAGENT, an agentic framework that automatically synthesizes, calibrates, verifies, and refines epidemiological simulators by modeling disease progression as an iterative program synthesis problem. A central design choice is an explicit epidemiological flow graph intermediate representation that links scenario specifications to model structure and enables strong, modular correctness checks before code is generated. Verified flow graphs are then compiled into mechanistic models supporting interpretable parameter learning under physical and epidemiological constraints. Evaluation on epidemiological scenario case studies demonstrates that EPIAGENT captures complex growth dynamics…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCOVID-19 epidemiological studies · Mathematical and Theoretical Epidemiology and Ecology Models · Artificial Immune Systems Applications
